Abstract
New evidence suggests that leptin and other anorexigenic agents reduce appetite by inactivating hypothalamic AMP-activated protein kinase (AMPK), thereby increasing malonyl CoA levels. This preview examines AMP biology and its role in malonyl-CoA generation and attempts to integrate its central actions with its peripheral antilipotoxic actions within the context of leptin physiology in obesity.
Original language | English (US) |
---|---|
Pages (from-to) | 145-146 |
Number of pages | 2 |
Journal | Cell |
Volume | 117 |
Issue number | 2 |
DOIs | |
State | Published - Apr 16 2004 |
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology